Viera Fertility CenterFebruary 3, 2023

FDA 483 - Viera Fertility Center - February 03, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of Viera Fertility Center in Melbourne, FL, identified a significant issue regarding donor screening practices. The firm failed to adequately screen donors for risk factors of communicable disease agents, specifically concerning Zika virus (ZIKV) transmission. This indicates a potential risk in their reproductive establishment operations.

Company: Viera Fertility Center
Inspection Date: February 3, 2023
Product Type: Other
Office: Office of Medical Device and Radiological Health Division II
Person: Lura Baquero

Open in Dashboard

ID · 714d443f-fdbe-4c7b-92de-9abb8c12ec10